Before starting Ozempic or Tirzepatide, we encourage a comprehensive consultation to assess your medical history, current health status, and past weight management efforts
Currently, MASLD is the most common chronic liver disease worldwide, affecting approximately 30% of the global adult population, with prevalence rates reaching 60-70% among patients with T2D 2,3
Under normal conditions, Keap1 helps target Nrf2 for degradation through a Cul3-based ubiquitin ligase complex
Another novel and salient finding from the current study is that enhancing the dietary intake of glycine increased the enzymatic activities of AGAT and GMAT, as well as the concentrations of both creatine and phosphocreatine in the skeletal muscle of HSB

Dehydration : Manifests as decreased urination, dark urine, dry mouth, dizziness upon standing, and fatigue Cardiovascular symptoms may occur, particularly as secondary effects of dehydration or anxiety: Increased heart rate (tachycardia) Palpitations or irregular heartbeat Lightheadedness or fainting Potential signs of pancreatitis (a rare but serious adverse effect): Severe, persistent abdominal pain, often radiating to the back Pain that worsens after eating Nausea and vomiting that doesn't resolve Tenderness when touching the abdomen Other potential symptoms include: Severe fatigue or weakness Headache Visual disturbances (if hypoglycemia develops) Altered mental status or confusion Symptom onset may begin within hours of injection but often intensifies over 1-2 days, aligning with tirzepatide's pharmacokinetic profile (peak concentration at approximately 24-48 hours)